Nuances of Phase I Study Conduct

Instructor: Lorraine S DeCesare
Product ID: 701556
  • Duration: 90 Min

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section
Last Recorded Date: Feb-2010

Training CD / USB Drive

One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-362-2367


Read Frequently Asked Questions

This webinar will discuss how Phase I studies differ from Phase III studies and how to best conduct and monitor Phase I studies.

Why Should You Attend:
A Phase I study is uniquely different from Phase II to Phase IV research. Phase I studies do not have any therapeutic benefit for the participant and, in fact, generally involve normal, healthy volunteers not patients with a specific illness. Phase I studies are conducted in a very strict environment. This session will discuss these unique attributes and ways both the site and the monitor can effectively manage such studies.

Areas Covered in the Seminar:

  • What is a Phase I study?
  • How do Phase I studies differ from Phase III studies - what are the idiosyncrasies of Phase I studies?
  • Ways to prepare to conduct a Phase I study.
  • How to effectively monitor a Phase I study.

Who Will Benefit:

This webinar will provide valuable insight to: sites wanting to expand their capabilities to include Phase I studies as well as those sites that conduct Phase III studies and CRA's who monitor Phase III studies who want to expand their realm of expertise. Persons who will benefit the most include:
  • Phase I site staff
  • CRA's currently monitoring Phase I studies
  • CRA's wanting to transition from Phase III monitoring

Instructor Profile:
Lorraine S.DeCesare, is founder of LS Drug Development, Inc., a consulting company specializing in site training, clinical trial management and project management services to all entities in the pharmaceutical industry. Ms. DeCesare, a pharmacist, has been in clinical research for over 30 years and has been involved in the start-up, development, and training of several Phase I units, as well as managing, coordinating, and monitoring multi-national programs with Phase I to Phase IV studies.

Follow us :
Latin America: Regulatory Compliance Requirements for Life Science Products
CLIA Waiver and Dual 510(k) CLIA Waiver Submissions to FDA

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed